Simple Summary The combination of positron emission tomography (PET)-diagnostics with
ligands binding to the prostate-specific membrane antigen (PSMA) has been a diagnostic …

Introduction In the last decade, two new radionuclide-based therapies, 223Radichloride and
radioligand therapy (RLT) targeting prostate-specific membrane antigen (PSMA), have been …

Simple Summary Prostate Specific Membrane Antigen-Positron Emission Tomography
(PSMA-PET) is currently recommended to stage Prostate Cancer (PCa) patients with …

The aim of this systematic review is to provide a comprehensive overview of the role of fluoro-
5α-dihydrotestosterone ([18F]-FDHT) for the in vivo imaging of androgen receptors (AR) …

Major advances in prostate cancer diagnosis, staging, and management have occurred over
the past decade, largely due to our improved understanding of the technical aspects and …

Prostate cancer (PCa) is the most frequently diagnosed cancer worldwide and the second
most common cause of cancer-related deaths among men. Progress in molecular imaging …

Purpose During the last decade,[18F] F-choline positron emission tomography (PET) had a
rising role in prostate cancer (PCa) imaging. However, despite auspicious premises,[18F] F …

Background: in recent years, the role of positron emission tomography (PET) and
PET/computed tomography (PET/CT) has emerged as a reliable diagnostic tool in a wide …

Recent developments in hybrid SPECT/CT systems and the use of cadmium-zinc-telluride
(CZT) detectors have improved the diagnostic accuracy of bone scintigraphy. These …

The aim of this study is to investigate the role of [18 F]-PSMA-1007 PET in differentiating
high-and low-risk prostate cancer (PCa) through a robust radiomics ensemble model. This …